Profile - To The Moon

bcwy

Posts · 24Posts · 24
Following · 0Following · 0
Followers · 0Followers · 0

- bcwybcwy
  ·2021-06-18
  Shell out more money
  Sorry, this post has been deleted
  5.19K Comment
  3
  Share
  Report
- bcwybcwy
  ·2021-06-18
  Uh oh, maybe business will fold soon
  Sorry, this post has been deleted
  5.33K Comment
  1
  Share
  Report
- bcwybcwy
  ·2021-06-18
  Uh oh orphazyme
  5.13K Comment
  Like
  Share
  Report
- bcwybcwy
  ·2021-06-18
  Ok here we go
  At Home Group accepts Hellman & Friedman's raised offer
  June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equ
  At Home Group accepts Hellman & Friedman's raised offer
  4.98K Comment
  Like
  Share
  Report
- bcwybcwy
  ·2021-06-18
  Wow who would've guessed
  Sorry, this post has been deleted
  5.45K Comment
  1
  Share
  Report
- bcwybcwy
  ·2021-06-18
  This is so sad
  Orphazyme shares tumbled more than 60% in pre-market trading
  Orphazyme shares tumbled more than 60% in pre-market trading. Orphazyme slashed its financial foreca
  Orphazyme shares tumbled more than 60% in pre-market trading
  7.11K 1
  2
  Share
  Report
- bcwybcwy
  ·2021-06-18
  Ford looks good to buy
  Sorry, this post has been deleted
  8.07K 1
  7
  Share
  Report
- bcwybcwy
  ·2021-06-18
  They will always win
  Sorry, this post has been deleted
  5.87K Comment
  Like
  Share
  Report
- bcwybcwy
  ·2021-06-18
  Post here
  5.41K Comment
  Like
  Share
  Report
- bcwybcwy
  ·2021-06-18
  Apple try harder
  Sorry, this post has been deleted
  5.49K Comment
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3582871469502818","uuid":"3582871469502818","gmtCreate":1619778373061,"gmtModify":1619778373061,"name":"bcwy","pinyin":"bcwy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":0,"tweetSize":24,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-4","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Tiger Star","description":"Join the tiger community for 2000 days","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.10.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":166644647,"gmtCreate":1624008474089,"gmtModify":1703826433205,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Shell out more money","listText":"Shell out more money","text":"Shell out more money","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166644647","repostId":"1181667218","repostType":4,"isVote":1,"tweetType":1,"viewCount":5191,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166642240,"gmtCreate":1624008407380,"gmtModify":1703826430938,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Uh oh, maybe business will fold soon","listText":"Uh oh, maybe business will fold soon","text":"Uh oh, maybe business will fold soon","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166642240","repostId":"1176081814","repostType":4,"isVote":1,"tweetType":1,"viewCount":5328,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166646213,"gmtCreate":1624008372332,"gmtModify":1703826429326,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Uh oh orphazyme","listText":"Uh oh orphazyme","text":"Uh oh orphazyme","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166646213","isVote":1,"tweetType":1,"viewCount":5125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648869,"gmtCreate":1624008279651,"gmtModify":1703826427502,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Ok here we go","listText":"Ok here we go","text":"Ok here we go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648869","repostId":"2143926717","repostType":2,"repost":{"id":"2143926717","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623854867,"share":"https://ttm.financial/m/news/2143926717?lang=en_US&edition=fundamental","pubTime":"2021-06-16 22:47","market":"us","language":"en","title":"At Home Group accepts Hellman & Friedman's raised offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2143926717","media":"Reuters","summary":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equ","content":"<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>At Home Group accepts Hellman & Friedman's raised offer</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAt Home Group accepts Hellman & Friedman's raised offer\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-16 22:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman &amp; Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.</p>\n<p>Plano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.</p>\n<p>Honest Capital said in May, in a letter to At Home, the initial offer from Hellman &amp; Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.</p>\n<p>At Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.</p>\n<p>\"This price increase represents our best and final offer,\" Hellman &amp; Friedman Partner Erik Ragatz said in a statement on Wednesday.</p>\n<p>H&amp;F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.</p>\n<p>Honest Capital could not be immediately reached for a comment, and CAS did not immediately respond.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2143926717","content_text":"June 16 (Reuters) - At Home Group Inc accepted a raised cash offer of $37 per share from private-equity firm Hellman & Friedman for the home decor chain, months after an earlier bid from the private-equity firm faced opposition from hedge fund Honest Capital.\nPlano, Texas-based At Home Group said the new offer represented a premium of about 21% to the closing stock price on May 4, a day before reports of a potential deal surfaced. The initial offer of $36 per share represented a premium of about 17%.\nHonest Capital said in May, in a letter to At Home, the initial offer from Hellman & Friedman was too low a valuation, given the company's plans to more than double the number of its stores to 600.\nAt Home's largest shareholder CAS Investment Partners had also said, according to a letter obtained by Reuters, it would vote against the deal, saying the first offer grossly undervalued the home decor chain.\n\"This price increase represents our best and final offer,\" Hellman & Friedman Partner Erik Ragatz said in a statement on Wednesday.\nH&F will commence a tender offer around June 23 to acquire all outstanding shares of At Home's common stock, At Home Group said.\nHonest Capital could not be immediately reached for a comment, and CAS did not immediately respond.","news_type":1,"symbols_score_info":{"HOME":0.9}},"isVote":1,"tweetType":1,"viewCount":4978,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166648341,"gmtCreate":1624008259483,"gmtModify":1703826427179,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Wow who would've guessed","listText":"Wow who would've guessed","text":"Wow who would've guessed","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166648341","repostId":"1113093847","repostType":4,"isVote":1,"tweetType":1,"viewCount":5452,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641587,"gmtCreate":1624008226649,"gmtModify":1703826426373,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"This is so sad","listText":"This is so sad","text":"This is so sad","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641587","repostId":"1142916683","repostType":4,"repost":{"id":"1142916683","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1624003342,"share":"https://ttm.financial/m/news/1142916683?lang=en_US&edition=fundamental","pubTime":"2021-06-18 16:02","market":"us","language":"en","title":"Orphazyme shares tumbled more than 60% in pre-market trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1142916683","media":"Tiger Newspress","summary":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial foreca","content":"<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orphazyme shares tumbled more than 60% in pre-market trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrphazyme shares tumbled more than 60% in pre-market trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-18 16:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Orphazyme&nbsp;shares&nbsp;tumbled&nbsp;more&nbsp;than&nbsp;60% in pre-market&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/b722b82c7d6ab2a6fcc7364eb2517b7f\" tg-width=\"1293\" tg-height=\"628\" referrerpolicy=\"no-referrer\">Orphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.</p>\n<p>Orphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.</p>\n<p>As a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.</p>\n<p>\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.</p>\n<p>Orphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142916683","content_text":"Orphazyme shares tumbled more than 60% in pre-market trading.\nOrphazyme slashed its financial forecasts on Friday after U.S. health regulators rejected its key drug candidate.\nOrphazyme said its application for FDA approval of arimoclomol, a treatment for genetic disorder Niemann-Pick disease type C, had not been successful.\nAs a result, it predicted revenue for the year would be lower than previously expected and its operating loss significantly wider, forcing the company to cut costs.\n\"Orphazyme has no money and no substantial projects ... Investors have put their money into a completely unrealistic scenario driven by 'meme tendencies',\" broker Nordnet wrote in a note to clients.\nOrphazyme, which is listed in Copenhagen and New York, now expects an operating loss of 670-700 million crowns ($107-$112 million) in 2021, against a previous forecast for a loss of 100-150 million crowns.","news_type":1,"symbols_score_info":{"ORPH":0.9}},"isVote":1,"tweetType":1,"viewCount":7113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641861,"gmtCreate":1624008197353,"gmtModify":1703826426041,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Ford looks good to buy&nbsp;","listText":"Ford looks good to buy&nbsp;","text":"Ford looks good to buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166641861","repostId":"2144172072","repostType":4,"isVote":1,"tweetType":1,"viewCount":8072,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166641940,"gmtCreate":1624008161080,"gmtModify":1703826425716,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"They will always win","listText":"They will always win","text":"They will always win","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/166641940","repostId":"2144861727","repostType":2,"isVote":1,"tweetType":1,"viewCount":5865,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168358986,"gmtCreate":1623953223445,"gmtModify":1703824605541,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Post here","listText":"Post here","text":"Post here","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168358986","isVote":1,"tweetType":1,"viewCount":5409,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":168351480,"gmtCreate":1623953188340,"gmtModify":1703824605213,"author":{"id":"3582871469502818","authorId":"3582871469502818","name":"bcwy","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3582871469502818","idStr":"3582871469502818"},"themes":[],"title":"","htmlText":"Apple try harder","listText":"Apple try harder","text":"Apple try harder","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168351480","repostId":"1139981231","repostType":2,"isVote":1,"tweetType":1,"viewCount":5490,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}